Japan Eyes Cutting Reimbursement For COVID-19 Drugs

Large Reduction For Xocova?

 
• By Lisa Takagi
Balancing NHI system and the market’s demand for accessible drugs for COVID-19 can be a challenging task.
Japan's challenge to balance NHI system and market demand for COVID-19 drugs • Source: Shutterstock

More from Japan

More from Asia